We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Ultracompact Microscope Enables High-Performance Imaging for Biomedical Diagnosis

By LabMedica International staff writers
Posted on 01 Aug 2022
Print article
Image: A chip-scale metalens array makes this microscope system ultracompact (Photo courtesy of Nanjing University)
Image: A chip-scale metalens array makes this microscope system ultracompact (Photo courtesy of Nanjing University)

Metalens technology opens a new way to achieve ultracompact and lightweight optical imaging systems. A metalens is a kind of metasurface composed of subwavelength units with powerful capability for manipulating light. An innovative polarization multiplexed metalens array (based on silicon nanoposts) was proposed to realize a compact and wide-field microscope that breaks conventional field-of-view (FOV) constraints, but the imaging quality is relatively poor due to its low efficiency with background noise, and the overall FOV is still smaller than that of traditional microscope with the same resolution. Significantly improved imaging quality is now possible with higher-resolution imaging, thanks to researchers who developed a polarizer-embedded metalens imaging device (PMID).

The PMID developed by researchers from Nanjing University (Jiangsu, China) is implemented based on a silicon nitride metasurface mounted on a CMOS image sensor with a fixed circular-polarization filter inserted between the two. It eliminates background noises, and even enables zoom-in imaging. The new system is based on a special co-and-cross-multiplexed metalens array and embedded polarizer. By integrating them to a chip-scale CMOS sensor, the researchers successfully developed a high-quality wide FOV and large depth-of-field (DOF) microscopy technique.

Significantly high performances are achieved, with a 4×4-mm2 FOV, a 1.74-μm resolution (limited by the CMOS pixel size), and a ~200-μm DOF (450-510-nm wavelength range). This FOV is around 5 to 7 times that of a traditional microscope with the same resolution. The team demonstrated the outstanding microscopy performance by imaging a large number of bio-specimens. This chip-scale microscope promises to revolutionize traditional optical devices, presenting a new horizon of ultracompact imaging devices powered by metatechnology.

“To the best of our knowledge, this is the first time a metalens imager has accessed a larger FOV than a traditional microscope with similar imaging quality,” said Tao Li, senior author and principal investigator at Nanjing University’s National Laboratory of Solid-State Microstructures. “By sweeping the illumination wavelength, the device is able to achieve large depth-of-field imaging simultaneously, thanks to the large dispersive nature of the metalens. This chip-scale PMID enables the implementation of miniaturized portable microscope system, with a thousand-fold reduction in volume and weight compared to a traditional microscope.”

Related Links:
Nanjing University 

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.